IncFact
Company Profiles: Revenue, Growth, Competition

ACADIA PHARMACEUTICALS Revenue, Growth & Competitor Profile

Last updated:

Company Awards

 
Public Company
public company
Big Fish
Big Fish
Brain Power (IP)
Patent/Trademark IP
 

Company Profile & Annual Report for Acadia Pharmaceuticals

Access the complete profile.

Acadia Pharmaceuticals Fast Facts

Revenue$100 - $500 million    See Exact Annual Revenue
Employees100 - 500Exact Company Size
Primary Industry5417 Scientific Research & Development Services
Additional NAICS Codes325412 Pharmaceutical Preparation Manufacturing
Address3611 Valley Centre Drive
Suite 300
San Diego, CA 92130

www.acadia-pharm.com


Acadia Pharmaceuticals's annual revenues are $100-$500 million (see exact revenue data) and has 100-500 employees. It is classified as operating in the Scientific Research & Development Services industry.


Acadia Pharmaceuticals's Annual Report & Profile shows critical firmographic facts:
  • What is the company's size? (Annual sales and employees)
  • What industry is the company in?

Acadia Pharmaceuticals is a publicly traded company on NMS using the ticker symbol ACAD. Detailed information on company financials and operating reports can be found here: NMS: ACAD



Acadia Pharmaceuticals Annual Revenue and Growth Rate

Acadia Pharmaceuticals Revenue Est.
($ Million)
Growth Rate (%)# Employees
2019 Details in Premium Report
2018
2017
2016
2015
2014


1-Year Growth Rate:
3-Year Growth Rate (CAGR):
Premium Report

Note: Acadia Pharmaceuticals's revenues are gauged from an analysis of company filings.



Investor Activity

Acadia Pharmaceuticals has actively raised capital from investors. These investors may include private investors, venture capital firms, or other investment vehicles.

Date Investors Percent Raised Target Size
January 2, 2013 29 100%$86 MM
Complete list of funding rounds and total amounts in the Company Report




Trademark Applications

Trademark applications show the products and services that Acadia Pharmaceuticals is developing and marketing. Acadia Pharmaceuticals's new tradmarks suggest it is investing in R&D and marketing, while expanding into new products or markets. Trademarks may include brand names, product names, logos and slogans.

Trademark Date
ACADIA CONNECT
Publications in the nature of brochures, pamphlets, newsletters, articles and guidebooks in the field of medical information and patient support
05/07/2020
MORE TO PARKINSON'S
Educational services providing information regarding Parkinson's disease for patients, caregivers and health care professionals
11/21/2017
NUPLAZIDCONNECT
Publications in the nature of brochures, pamphlets, newsletters, articles and guidebooks in the field of medical information and patient support
04/26/2016

See all trademarks and details in the Full Report.


Recession Risk

Determine whether Acadia Pharmaceuticals grew or shrank during the last recession. This is useful in estimating the financial strength and credit risk of the company. Compare how recession-proof Acadia Pharmaceuticals is relative to the industry overall. While a new recession may strike a particular industry, measuring the industry and company's robustness during the last recession estimates its ability to weather future recessions.



U.S. Industry Overview & Market Statistics:
Scientific Research & Development Services

Publisher: AnythingResearch

  • Market Size
  • Growth Rate
  • 5-Year Market Forecast
  • Average Company Size & Growth
  • Salary & Compensation Benchmarks



Market Share of Acadia Pharmaceuticals's Largest Competitors

A competitive analysis shows these companies are in the same general field as Acadia Pharmaceuticals, even though they may not compete head-to-head. These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines. The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies. Competitive advantage comes from offering better pricing or superior products/service.

Company HeadquartersRevenue ($ MM)
INC RESEARCHMorrisville, NC100 
LEIDOSReston, VA53 
SCIENCE APPLICATIONS INTERNATIONALReston, VA33 
NATIONAL TECHNOLOGY & ENGINEERING SOLUTIONS OF SANDIAAlbuquerque, NM28 
BIOMERIEUXDurham, NC19 
SYNEOS HEALTHRaleigh, NC18 
INCYTEWilmington, DE18 
COVANCEPrinceton, NJ16 
FLUOR MARINE PROPULSIONWest Mifflin, PA16 




Nearby Competitors

These companies are similar in business line and location to Acadia Pharmaceuticals. While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.

Company HeadquartersRevenue ($ MM)
ILLUMINASan Diego, CA100 
NEUROCRINE BIOSCIENCESSan Diego, CA13 
SORRENTO THERAPEUTICSSan Diego, CA9 
PSEMISan Diego, CA9 
ACADIA PHARMACEUTICALSSan Diego, CA8 
SAMUMEDSan Diego, CA7 




Future Competition: Acadia Pharmaceuticals's Fastest Growing Competitors

These companies are in the same general field as Acadia Pharmaceuticals and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.

CompanyRevenue ($ MM)
Acadia Pharmaceuticals Competitors